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ParabiosisAdiponectin is exclusively synthesized by adipocytes and exhibits anti-diabetic, anti-atherosclerotic
and anti-inﬂammatory properties. Hypoadiponectinemia is associated in obese individuals with
insulin resistance and atherosclerosis. However, the mechanisms responsible for hypoadiponectin-
emia remain unclear. Here, we investigated adiponectin movement using hetero parabiosis model
of wild type (WT) and adiponectin-deﬁcient (KO) mice. WT mice were parabiosed with WT mice
(WT–WT) or KO mice (WT–KO) and adiponectin levels were measured serially up to 63 days after
surgery. In theWT–KO parabiosis model, circulating adiponectin levels of theWT partners decreased
rapidly, on the other hand, those of KO partners increased, and then these reached comparable lev-
els each other at day 7. Circulating adiponectin levels decreased further to the detection limit of
assay, and remained low up to day 63. However, adiponectin protein was detected in the adipose tis-
sues of not only the WT partner but also WT–KO mice. In the diet-induced obesity model, high
adiponectin protein levels were detected in adipose stromal vascular fraction of diet-induced obese
KO partner, without changes in its binding proteins. The use of parabiosis experiments shed light on
movement of native adiponectin among different tissues such as the state of hypoadiponectinemia
in obesity.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Obesity, especially visceral fat accumulation, is closely associ-
ated with chronic inﬂammation of the adipose tissue, which results
in adipocyte dysfunction and dysregulated production of adipocy-
tokines, leading to systemic metabolic disorders and atherosclero-
sis [1,2]. The adipocytokine, adiponectin [also known as adipocyte
complement-related protein of 30 kDa (ACRP30), adipoQ and
gelatin binding protein of 28 kDa (GBP28)], was discovered inde-
pendently by our group and three other groups of investigators
[3–7], and is exclusively synthesized by adipocytes. In experimen-
tal studies, adiponectin exhibits anti-diabetic, anti-atherosclerotic,and anti-inﬂammatory properties [8]. Adiponectin is present at
high levels (3–30 lg/mL) in the blood of normal subjects, but the
circulating levels are low in obese individuals [9]. Studies from
our laboratories indicate that reactive oxygen species (ROS),
ischemia and adipose hypoxia result in dysregulated production
of adiponectin [10,11]. We also reported that hypoadiponectin-
emia could occur without apparent change in adiponectin mRNA
expression [12,13]. Hence, the mechanism of the catabolism and
clearance of adiponectin in obesity remains to be elucidated.
Although several in vitro and in vivo studies have investigated
the short-term effects of adiponectin using adenovirus-induced
or recombinant adiponectin [14–16], the relative long-term effects
of adiponectin-knockout (KO) mice remains unclear.
Parabiosis is the surgical union of two animals that leads to
development of common circulation and allows the investigation
of circulating factors in the regulation of physiologic systems
[17]. In mice, the reported rate of blood exchange between para-
biotic partners is 2.0 ± 0.2% per min (range, 0.71–3.1%) [17]. In
the present study, we analyzed the localization of adiponectin
using parabiosis model, chronic recruitment of adiponectin, in
KO mice.
Table 1
Sequences of the primers used in the present study.
Gene Forward (50–30) Reverse (50–30)
Adiponectin GATGGCAGAGATGGCACTCC CTTGCCAGTGCTGCCGTCAT
AdipoR1 ATGGAGAAGATGGAGGAGTTCGT TCTTGAAGCAAGCCCGAAA
AdipoR2 TCCCAGGAAGATGAAGGGTTTAT TTCCATTCGTTCGATAGCATGA
Calreticulin TACGCACTGTCCGCCAAAT GTCCAAACCACTCGGAAACAG
T-cadherin GCCCTCGTGAGCCTTCTTC CACCCTGAGGTCCGTGATGT
36B4 GGCCAATAAGGTGCCAGCT ATCAGCCCGAAGGAGAAG
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2.1. Animal models
Male wild-type (WT) mice with a C57BL/6J background were
obtained from Clea Japan (Tokyo, Japan). KO mice were generated
and backcrossed, as described previously by our group [18]. Mice
were acclimated to the new environment for at least one week be-
fore the experiments and kept in rooms set at 22 C with a 12–12 h
dark–light cycle (light cycle, 8 am to 8 pm).
At 12–14 weeks of age,WTmice parabiosedwithWTmice (WT–
WT) or KO mice (WT–KO). Parabiotic surgery was performed using
the protocol described previously [17]. Brieﬂy, after anesthesia, the
corresponding lateral aspects of each mouse were shaved, and a
longitudinal skin incision from the shoulder to the knee joint was
made on one side of each animal. The muscles were removed from
the scapulae, and the bones were sutured together. The walls of the
peritoneal cavities were incised (5 mm long), sutured together to
form a peritoneum tunnel. Themuscles around the scapulae and fe-
murs were sutured together. Finally, the skin was sutured to create
a single paired-animal. After surgery, the partners were housed one
pair per cage, and food [Normal chow (NC) or high fat/high sucrose
diet (HF/HS) (F2HFD2, Oriental Yeast, Osaka, Japan)] was provided
in dish plate on the ﬂoor to ensure easy access.
Before surgery and 4–63 days postoperatively, venous blood
samples (50 lL each) were collected from the tail vein at the indi-
cated time periods. Serial plasma adiponectin levels weremeasured
by adiponectin enzyme-linked immunosorbent assay (ELISA) kit
(Otsuka Pharmaceutical Co. Tokushima, Japan). Serial plasma glu-
cose and insulin levels were measured by the Glucose CII-Test
(Wako Pure Chemical, Osaka, Japan) and Ultra Sensitive Insulin ELI-
SA Kit (Morinaga, Kanagawa, Japan), respectively. At 9 weeks after
parabiotic surgery, mice under anesthesia were separated immedi-
ately from parabiotic-pair and then blood was collected for plasma
assay. Next, mice was injected with 20 mL saline into the cardiac
apex followed by collection of the entire blood volume. Further-
more, the subcutaneous (WATsub) and mesenteric white adipose
tissues (WATmes) as well as various organs were excised for analy-
sis. The experimental protocol was approved by the Ethics Review
Committee for Animal Experimentation of Osaka University School
of Medicine. Each experiment was repeated at least three times.
2.2. Isolation of mouse mature adipocyte fractions and stromal
vascular fractions
WATsub and WATmes from each mice were fractionated, as de-
scribed previously in detail by our group [19]. The adipose tissues
were minced in Krebs-Ringer bicarbonate HEPES (KRBH) buffer
[containing 120 mmol/L NaCl, 4 mmol/L KH2PO4, 1 mmol/L MgSO4,
1 mmol/L CaCl2, 10 mmol/L NaHCO3, 30 mmol/L HEPES, 20 lmol/L
adenosine, and 4% (wt/vol) bovine serum albumin (Calbiochem,
San Diego, CA)]. Tissue suspensions were centrifuged at 500g for
5 min to remove erythrocytes and free leukocytes. Collagenase
was added to a ﬁnal concentration of 2 mg/mL and incubated at
37 C for 30 min under continuous shaking. The cell suspension
was ﬁltered through a 250 lm ﬁlter and then spun at 300g for
1 min to separate ﬂoating mature adipocytes fraction (MAF) from
the stromal vascular cell fraction (SVF) pellet. The fractionation
and washing procedures were repeated twice with KRBH buffer. Fi-
nally, both fractions were washed with calcium- and magnesium-
free phosphate buffered saline (PBS).
2.3. Western blot analysis
Equal amounts of plasma and protein (8–10 lg) samples
extracted from various tissues were incubated with a reducingsample buffer (containing 2% SDS, 50 mM Tris–HCl, pH 6.8, and
10% glycerol with 2-mercaptoethanol), boiled for 5 min and sepa-
rated by 4–20% gradient sodium dodecyl sulfate–polyacrylamide
gel electrophoresis (SDS–PAGE). Immunoblot analysis was per-
formed with ﬁrst antibody adiponectin at a 1:2000 dilution (Rabbit
polyclonal antibody to mouse adiponectin, Otsuka Pharmaceutical
Co., Tokyo), followed by incubation with secondary antibody con-
jugated with horseradish peroxidase at a 1:2000 dilution (Goat
anti-rabbit IgG horseradish peroxidase conjugate, GE Healthcare,
Uppsala, Sweden). The ECL prime system (GE Healthcare) was used
for detection of the protein signal. The intensity of the blots was
quantiﬁed with the National Institutes of Health NIH image analy-
sis software (v1.62, Bethesda, MD).
2.4. Quantiﬁcation of mRNA level
Total RNA was isolated from mouse tissues by using RNA STAT-
60 (Tel-Test, Inc., Friendswood, TX) according to the protocol sup-
plied by the manufacturer. The quality and quantity of total RNA
were determined by spectrophotometry (model ND-1000, Nano
Drop Technologies, Wilmington, DE). First-strand cDNA was
synthesized from total RNA using Thermoscript RT (Invitrogen,
Carlsbad, CA) and oligodT primer. Real-time quantitative PCR
ampliﬁcation was conducted with the 7900HT system (Applied
Biosystems, Forester City, CA) using Thunderbird qPCR mix (Toy-
obo, Osaka, Japan) according to the protocol recommended by
the manufacturer. Table 1 lists the sequences of the primers used
in the present study.
2.5. Histological examination
Parafﬁn samples were dehydrated through an ethanol series,
washed three times in xylene, embedded in parafﬁn and stored
at 4 C. Parafﬁn samples were sectioned at 8 lm. The tissue sec-
tions were processed for routine hematoxylin–eosin staining. Data
were collected from ﬁve individual views per WAT. The area of adi-
pocytes was traced manually and measured in 200 cells per mouse
by using Win ROOF 5.5 software (Mitani Co, Fukui, Japan).
2.6. Statistical analysis
Data are expressed as mean ± SEM. Differences between groups
were examined for statistical signiﬁcance using the Student t-test
or ANOVA with the Fisher protected least signiﬁcant difference
test. In all cases, p values <0.05 were considered statistically signif-
icant. All statistical analyses were performed with The Statistical
Package for Social Sciences (version 11.0, SPSS Inc, Chicago, IL).
3. Results
3.1. Parabiosis between WT and KO mice
To investigate the effects of long-term adiponectin recruitment
in adipose tissues, WT mice were parabiosed with WT mice
(WT–WT) or KO mice (WT–KO) (Fig. 1A). There was no signiﬁcant
difference in body weight of WT–WT and WT–KO pairs (Fig. 1B).
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similar levels in WT partners of WT–WT [WT (WT–WT)], WT part-
ners of WT–KO [WT (WT–KO)] and KO partners of WT–KO [KO
(WT–KO)] (Fig. 1C). Serial measurements of circulating adiponectin
levels by ELISA showed increased levels at day 14 in WT (WT–WT),
followed by plateau at 15–18 lg/mL (Fig. 1C). This was in contrast
to WT (WT–KO) parabiotic mice, which showed rapid fall in circu-
lating adiponectin levels. On the other hand, the levels in KO (WT–
KO) increased initially and then at day 7 reached levels comparable
to those of WT (WT–KO) (Fig. 1C). Previous reports showed that
cross-circulation was established by day 3 after parabiosis surgery
[20,21]. Our results showed that adiponectin migrated from WT
mice to KO mice through the bloodstream. Interestingly, since
day 7, circulating adiponectin levels decreased markedly below
the detection limit of ELISA assay, and remained at those low levels
up to day 63 (Fig. 1C).
3.2. Adiponectin protein in parabiosis mice
At day 63 after surgical parabiosis, each pair mice was sacriﬁced
and analyzed. There was no signiﬁcant difference in tissue weight
of WATsub and WATmes between WT (WT–WT), WT (WT–KO) and
KO (WT–KO) (Fig. 2A). Next, we examined the tissue distribution
of adiponectin protein in these mice. Both western blotting and
tissue ELISA assay showed abundant adiponectin protein levels in
WATsub, WATmes and aorta of WT (WT–KO), similar to WT
(WT–WT) (Fig. 2B). However, lower adiponectin protein levels
were detected in WATsub, WATmes and aorta of KO (WT–KO)
(Fig. 2B), which lacks adiponectin mRNA expression (Fig. 2C).n.s. 
A 
B 
0 
10 
40 
50 
60 
WT-KO 
WT-WT 
B
od
y 
w
ei
gh
t (
g)
 
Sacrifice Op 
0 
12-14- 
week-old 
63 days 
WT KO 
-1 4  7 14 21 28 35 42 49 56 63 
Time after surgery (days) 
WT WT : 5 pairs 
: 10 pairs 
Fig. 1. Effect of parabiosis. (A) Experimental protocol. WT mice were parabiosed with W
the mice were sacriﬁced and their tissues analyzed. WT; wild type mice, KO; adiponectin
glucose, insulin and adiponectin levels were measured in partners of parabiosed mice. W
(WT–KO); KO mice of WT–KO pair. Data are mean ± SEM. Each experiment was repeateTo further investigate adiponectin accumulation in WAT, we
determined mRNA gene expression of adiponectin, adiponectin
receptors and binding proteins genes in WATsub and WATmes
(Fig. 2C). Adiponectin mRNA levels were exclusively expressed in
WT (WT–WT) and WT (WT–KO), but not in KO (WT–KO). There
was no difference in mRNA levels between WT (WT–WT) and
WT (WT–KO) (Fig. 2C). Furthermore, there were no signiﬁcant dif-
ference in mRNA gene expression levels of putative adiponectin
receptors and binding molecules, AdipoR1, AdipoR2, calreticulin
and T-cadherin [22–25], between WATsub and WATmes of the three
mice groups (Fig. 2C).
3.3. Accumulation of adiponectin in stromal vascular fraction of HF/HS
diet parabiosis mice
Does adiponectin protein accumulate in WAT of obese mice
more than that of lean mice after long-term adiponectin recruit-
ment? To answer this question, we compared high fat/high sucrose
(HF/HS) diet-induced obese parabiosis WT and APN-KO mice and
parabiosis mice fed NC diet (Fig. 3A, B). HF/HS diet load was
provided at day 8 after operation, based on the ﬁnding of compa-
rable levels of plasma adiponectin levels at day 7 (Fig. 3C bottom).
The body weight of parabiotic partners slightly, but signiﬁcantly,
increased during the 8-week period of HF/HS feeding (Fig. 3B).
Plasma glucose levels were signiﬁcantly higher in WT (WT–KO)
fed HF/HS than WT (WT–KO) fed NC at days 14 and 21
(p = 0.0006, p < 0.0001 each), however, no such difference was ob-
served at day 63. Plasma insulin levels were signiﬁcantly higher in
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H. Nakatsuji et al. / FEBS Open Bio 4 (2014) 276–282 279(WT–KO) fed HF/HS; p = 0.0094 at day 14, p = 0.0222 at day 21,
p = 0.0256 at day 63, KO (WT–KO) fed NC vs. KO (WT–KO) fed
HF/HS; p = 0.0070 at day 14, p = 0.0079 at day 21, p = 0.0120 at
day 63]. In the HF/HS fed mice, plasma insulin levels were higher
in WT (WT-KO) than in KO (WT-KO). These data suggest that
adiponectin derived from WT (WT-KO) seems to improve insulin
resistance in KO (WT-KO), which lack native adiponectin.
Movement of circulating adiponectin levels in HF/HS-fed mice
was similar to that in NC-fed mice. At day 63, tissue weights of
WATsub and WATmes of mice fed HF/HS diet was signiﬁcantly high-
er than of mice fed NC diet (Fig. 4A). There was no signiﬁcant dif-
ference of tissue weight of WAT between WT and KO partners fed
both diets (Fig. 4A). Histological examination showed that adipo-
cytes in WATsub and WATmes of HF/HS-fed mice were larger than
those of NC-fed mice (Fig. 4B).
Finally, we identiﬁed the cell type that preferentially contrib-
uted to the observed adiponectin levels in both MAF and SVF iso-
lated from WAT. Adiponectin protein level was signiﬁcantly
higher in the SVF of HF/HS-fed mice than of NC-fed mice (WATsub:
p = 0.0327, WATmes: p = 0.0027, Fig. 4C). Furthermore, the mRNA
gene expression levels of AdipoR1, AdipoR2 and calreticulin in both
WATsub and WATmes and T-cadherin in WATsub were dominant in
MAF, and T-cadherin in WATmes was also higher in MAF than SVF
(Fig. 4D). However, there were no differences in the mRNA levels
of these putative adiponectin receptors and binding genes in SVF
as well as MAF between NC- and HF/HS-fed mice (Fig. 4D). These
results suggest that adiponectin accumulation in obese adipose tis-
sues may be accounted for by unknown adiponectin binding
machinery.4. Discussion
In the present study, we investigated the recruitment of adipo-
nectin in various tissues over a relatively long period of time. The
experiments were conducted in hetero parabiosis animals of WT
and KO mice. The results showed the presence of adiponectin pro-
tein in the plasma of KO (WT–KO) mice at day 4 after parabiosis,
suggesting adiponectin recruitment via the circulation from WT
mouse to the KO partner. Survey of adiponectin tissue distribution
demonstrated its accumulation in various tissues, especially the
adipose tissue. In KO (WT–KO), adiponectin protein was detected
in both MAF and SVF of WAT, and SVF adiponectin levels increased
in HF/HS diet-induced obesity. To clarify the mechanism of such
increase, we examined the gene expression levels of four putative
adiponectin receptors and binding proteins; AdipoR1, AdipoR2,
calreticulin and T-cadherin. Our recent experimental study demon-
strated that adiponectin accumulation in adipose SVF of obese
mice was mediated at least in part through ROS-upregulated
T-cadherin [26]. In present study, plasma thiobarbituric acid reac-
tive substance (TBARS) levels were slightly, but signiﬁcantly, high-
er in KO (WT–KO) mice fed HF/HS than in those fed NC (2.1 ± 0.2
vs. 1.7 ± 0.3 nmolMDA/mL, mean ± SD, p = 0.0058). However, we
did not ﬁnd any change in adiponectin binding proteins, including
T-cadherin by diet-induced obesity in parabiosis mice. The exact
mechanism of adiponectin accumulation remains to be elucidated.
The present study documented movement of circulating adipo-
nectin in hetero parabiosis of WT and KO mice. Plasma adiponectin
in WT (WT–KO model) decreased rapidly after parabiosis with KO
mice (Fig. 1). One possible reason for the fall in adiponectin in WT
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conceivable that adiponectin blood levels in WT–KO model dimin-
ish by 50% half at early postoperative period due to the doubling of
circulating blood volume after surgery. However, our analysis
showed that adiponectin blood concentrations reduced to around
the detection limit of the assay. In our study, adiponectin mRNA
levels in WATsub and WATmes were not different between WT
(WT–WT) andWT (WT–KO) (Fig. 2C), suggesting that the reduction
of adiponectin in blood was not due to failure in production. An-
other group conducted infusion study of labeled adiponectin in
mice, and reported that the main site for clearance of adiponectin
was the liver, and that the kidney might excrete the ﬁnal degrada-
tion products [27]. Excess degradation of adiponectin might have
occurred in parabiosis between WT and KO mice, but we could
not clarify that point.
Adiponectin levels did not ‘‘equilibrate’’ between the WT and
KO mouse over a 63 day period (Fig. 1). It appeared that adiponec-
tin derived from the WT mice fell into ‘‘bottomless pit’’ in KO mice
in this WT–KO parabiosis model. A potential explanation could be
that adiponetin KO mice have a vast number of binding sites in the
body, and that after adiponectin is restored it might take an
exceedingly long time, beyond the experimental period of 63 days,
to occupy these binding sites and to raise the plasma levels. How-
ever, this explanation seems implausible.
We reported recently that adiponectin formed a protein com-
plex with structurally-related complement C1q [28]. Exogenous
adiponection from WT may form such complexes with other pro-
teins in the blood of KOmice, which are then rapidly removed from
circulation.
We and others have reported that adiponectin accumulates in
injured organs, such as arterial walls [29,30], kidney [16], and liver[31]. Parabiosis experiments might cause severe injury in speciﬁc
organs and accumulation of adiponectin, although there was no
difference in the gross appearance or size of organs between WT
and KO mice in the WT–KO model in the present study (data not
shown). The pattern of tissue distribution of adiponectin protein
was similar in these mice (Fig. 2) and we did not ﬁnd adiponectin
accumulated in the organs speciﬁc for parabiosis.
The present study demonstrated that adiponectin protein from
WT mice was distributed in various tissues of the body of KO mice,
especially in its source tissue (i.e. adipose tissue), similar to WT.
Exogenous adiponectin may be utilized and catabolized quite rap-
idly in KO mouse by unknown mechanism because of the lack of
endogenous adiponectin. The molecular mechanism of such
‘‘adiponectin-inducible clearance system’’ may be clariﬁed in the
future. To our knowledge, this report is the ﬁrst to investigate
blood and tissue adiponectin levels in parabiosis mice.
Interestingly, the present study found that plasma insulin levels
were signiﬁcantly higher in WT (WT–KO model) HF/HS fed mice
than in KO (WT–KOmodel) HF/HS fed mice (Fig. 3). These data sug-
gest that reduced adiponectin levels in WT (WT–KO model) HF/HS
fed (native adiponectin is presented) rather than replaced adipo-
nectin in KO (WT–KO model) HF/HS fed mice (native adiponectin
is not presented) may partly lead to hyper-insulinemia.
In conclusion, the present study demonstrated that hetero
parabiosis of WT and KO mice resulted in hypoadiponectinemia
in WT mice, as well as adiponectin accumulation in various tis-
sues, including WAT, in the KO partner, which lack adiponectin
gene expression, probably through recruitment of adiponectin
from the WT partner. Furthermore, diet-induced obesity in-
creased adiponectin protein level in adipose SVF of KO partner.
These ﬁndings shed light on the movement of native adiponectin
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